EDMOND DE ROTHSCHILD HOLDING S.A. - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 56 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 339.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2016$3,000
+50.0%
6250.0%0.00%
Q4 2015$2,0000.0%6250.0%0.00%
Q3 2015$2,000
-33.3%
6250.0%0.00%
Q2 2015$3,0006250.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,144,0000.82%
Northeast Financial Consultants Inc 732,265$988,0000.30%
Family Management Corp 10,424$14,0000.01%
LMR Partners LLP 81,550$110,0000.01%
ELEMENT CAPITAL MANAGEMENT LLC 148,528$201,0000.01%
Poehling Capital Management, INC. 3,302$4,0000.00%
Paloma Partners Management Co 143,800$194,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 186,254$251,0000.00%
FNY Investment Advisers, LLC 4,230$5,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders